Fundraising FoxValanbio Therapeutics
Raleigh, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into Valanbio Therapeutics
Sign up to see every warm intro you have to Valanbio Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Valanbio Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$421K disclosed across 1 of 2 rounds · 2018–2020
▶$421KraisedJan 2020 · 5 investors · PharmaceuticalsRule 506(b)
▶$421KraisedJan 2020 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Clayton DuncanExecutive Officer, Director
- Pei ZhouExecutive Officer, Director
- Moise A. KhayrallahExecutive Officer, Director
- Eric J. TooneDirector
- Sam HopkinsDirector
- Offering amount
- $600K
- Amount sold
- $421K
- Minimum investment
- $7K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Valanbio Therapeutics's investors?
- Valanbio Therapeutics's investors include Breakthrough Energy Ventures.
- How much funding has Valanbio Therapeutics raised?
- Valanbio Therapeutics has disclosed $421K raised across 1 of its 2 known rounds.
- Where is Valanbio Therapeutics headquartered?
- Valanbio Therapeutics is headquartered in Raleigh, US.